Companies: 10,795·Total market cap: $144.5T
Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation

NYMXFOTCHealthcare● Active
$0.09
+$0.00(+0.00%)
Market Cap$8508613
P/E Ratio—
52W High$0.1999
52W Low$0.03
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Nymox Pharmaceutical Corporation (NYMXF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001018735 · NYMXF · OTC · as of Jun 10, 2026

Filing snapshot

403
Total Filings
6-K
Latest Form
2026-06-03
Most Recent
1997
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001018735 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2025-06-03
Fiscal Year End
Jun 3, 2025
Accession No.
0001640334-25-000972
Primary Document
nymox_20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001018735 · Accession 0001640334-25-000972

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-06-03
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-06-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-27
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-11-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-10-22
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-10-22
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-09-23
View
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2025-06-03
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-05-22
View
NT 20-FNT 20-F
FORM 20-F
2025-05-01
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-03-11
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-01-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-12-17
View
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2024-08-29
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-07-18
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2024-07-16
View
Showing 1–15 of 308 filingsForm 4 / 144 hidden· 403 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001018735  |  Exchange: OTC · Healthcare

Nymox Pharmaceutical Corporation (OTC: NYMXF) has submitted 403 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1997. As a Healthcare sector company with CIK 0001018735, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Nymox Pharmaceutical Corporation's most comprehensive regulatory disclosure. The most recent Nymox Pharmaceutical Corporation 10-K was filed on 2025-06-03 for fiscal year ending 2025. Historical NYMXF 10-K annual reports are available from 1996 through 2025.

Investors researching Nymox Pharmaceutical Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
DVHGF SEC Filings →IMUC SEC Filings →INTI SEC Filings →HOOK SEC Filings →ALRTF SEC Filings →HMTXF SEC Filings →OXBOF SEC Filings →LVCLF SEC Filings →
→ NYMXF Financials→ NYMXF Earnings→ NYMXF Insider Trades

Frequently Asked Questions

NYMXF SEC Filings · 8 questions

Nymox Pharmaceutical Corporation (NYMXF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 403 filings and access original documents at no cost. Nymox Pharmaceutical Corporation's CIK is 0001018735.

NYMXF SEC filingsNymox Pharmaceutical Corporation SEC documentsfind NYMXF 10-K